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Abstract To understand the role of CASP9 (Caspase-9)
gene products in relation to neuroblastoma disease, we
have analyzed the single nucleotide polymorphisms (SNPs)
associated with this gene. This can help us understand the
genetic variations that can alter the function of the gene
products. A total of 941 SNPs are investigated for CASP9
gene. To determine whether a non-synonymous SNP
(nsSNP) in this gene affects its protein product, we used
certain computational tools which predicted one nsSNP,
rs1052574, to have deleterious phenotypic effect. This
polymorphic variant results in amino acid substitution from
leucine to proline at 197 position, i.e., from acyclic amino
acid to a 5-membered amino acid which resides in the
buried area of the protein with a high level of conservation.
This amino acid substitution shows a transition from helix
to coil in the mutant protein. Hence, due to the complete
alteration in the structural property of the amino acid side
chain, the stability of the protein is reduced which may
affect the function of CASP9 protein, leading to deregu-
lation of apoptosis and neuroblastoma development.
Keywords CASP9  Leucine  Neuroblastoma  Proline 
rs1052574
Introduction
Neuroblastoma (NB) is the most common extracranial tumor
of childhood, arising from neural crest cells, accounting for
approximately 10 % of pediatric cancers (Gale et al. 1982;
Brodeur et al. 1992; Schor 1999). NB is characterized by
diverse behavior ranging from rapid malignant progression
to spontaneous regression (Lastowska et al. 2001). It has
been suggested that genetic susceptibility to NB is now
highly probable (Shojaei-Brosseau et al. 2004). Attention
has been focused on determining the specific genetic alter-
ations in tumors affecting the prognosis and leading to tar-
geted therapies for the individual cancer patient (Heinrichs
and Look 2007). The most common form of genetic varia-
tion in the human genome are single nucleotide polymor-
phisms (SNPs), accounting for heritable inter-individual
variability in complex phenotypes (Liaoa and Lee 2010; Suh
and Vijg 2005). Several biological markers related to the
outcome of NB disease have been identified (Cattelani et al.
2008). Apoptosis, the process of cell elimination play a vital
role in maintaining cellular homeostasis, cell proliferation
and differentiation. Disturbances in the cell death process
may lead to uncontrolled cell growth and tumor formation
(Zhivotovsky and Orrenius 2006). It has been proposed that
aberrations in apoptosis contribute to NB progression (Abel
et al. 2005). Caspase-9 (CASP9) gene, a key regulator of the
apoptotic signaling system is mapped to the consensus
region deleted in all NB cases with 1p deletion (Ohira et al.
2000). Thus, it is considered to be a good candidate gene for
NB (Abel et al. 2002). Recent evidence suggests that
CASP9, a critical member of the mitochondrial-mediated
apoptotic protease cascade, is expressed to a low extent in
tumors of NB patients, suggesting that dysregulation of
apoptosis is likely to be instrumental in the development
or progression of childhood tumor neuroblastoma (Abel
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et al. 2002, 2005). Single nucleotide changes in CASP9
gene, leading to the reduced expression of the protein, have
been studied in NB tumors (Abel et al. 2002). Bioinformatics
tools used to screen the potentially deleterious SNPs based
on the gene of interest have been documented (Mah et al.
2011). Attention has been focused on non-synonymous
SNPs (nsSNPs) for an association study of genetic diseases
which can be useful to examine the potential impact of an
amino acid variant on the function of the encoded protein
(Johnson et al. 2005). The substitution of one amino acid for
another generally results in conformational changes in the
immediate vicinity of the substituted site which leads to a
significant alteration in thermodynamic stability of the sin-
gle mutant site from that of the corresponding native protein
(Shortle and Sondek 1995; Querol et al. 1996). A compu-
tational approach has also been employed to study the effect
of the protein stability upon mutation (Guerois et al. 2002).
Hydrogen bonding, being one of the major structural deter-
minants in protein molecules, helps us understand protein
structure and motions. It also contributes to the specificity of
intramolecular interactions in biological systems (Kortem-
mea et al. 2003). Such type of interactions can be affected by
any amino acid variant in the protein molecule due to
mutation (Wang and Moult 2001). Thus, to analyze the
intramolecular interactions upon mutations, we have carried
out a computational analysis of the hydrogen bonds
(H-bonds) across the modeled protein molecules.
We assume that there are no bioinformatics approaches
to document the decreased expression of mutated CASP9
gene. This prompted us to carry out the analysis of phe-
notypic impact of nsSNPs of CASP9 gene and their effect
on structural stability of the mutated protein. Our results
will provide an insight to the researchers for understanding
the regulatory role played by CASP9 in apoptosis and the
genetic consequence of NB.
Materials and methods
Data source
The SNPs associated with CASP9 gene were obtained from
the single nucleotide polymorphism database (dbSNP)
(Wheeler et al. 2008) and the reference SNP (rs) IDs are
listed in the Supplementary table. There was a total of 941
SNPs associated with CASP9.
F-SNP identifies nsSNPs by mining Ensembl database
For selecting nsSNPs of CASP9 gene, we used functional
single nucleotide polymorphism (F-SNP) database (Lee
and Shatkay 2008). The F-SNP database identified nsSNPs
that had deleterious effects on protein structure or function,
or impede post-translational modification (Lee and Shatkay
2008). The Ensembl database (Hubbard et al. 2009;
Ramensky et al. 2002) was mined to identify nsSNPs.
Ensembl provided the number of synonymous and non-
synonymous SNPs related to the gene of interest. Each
gene had an associated GeneSNPView page which showed
SNP locations and effects related to gene and protein
structures (Reumers et al. 2005).
Functional effects of nsSNPs are assessed using F-SNP
database
We used F-SNP database which provided a comprehensive
collection of functional information about SNPs with
respect to four biomolecular functional categories: protein
coding, splicing regulation, transcriptional regulation and
post-translation effects. To obtain the functional effects of
SNPs, it made use of large variety of publicly available
tools and resources (Lee and Shatkay 2008).
Mining different tools by F-SNP to predict
the functional effects of nsSNPs in protein coding
region
The tools that were utilized for identifying the coding
nsSNPs include Sorting Intolerant from Tolerant (SIFT)
(Ng and Henikoff 2003; Shen et al. 2006), Polymorphism
Phenotyping (PolyPhen) (Johnson et al. 2005; Zhu et al.
2008), SNPeffect (Reumers et al. 2005, 2006), large-scale
annotation of coding nsSNPs (LS-SNP) (Karchin et al.
2005; Ryan et al. 2009) and SNPs3D (Yue et al. 2006).
Identifying changes in the splicing regulation system
by F-SNP
F-SNP database mined certain computational prediction
tools that were developed for locating splicing elements
and identifying the exon/intron structures of genes (Car-
tegni et al. 2003). Exonic splicing enhancer (ESEfinder)
(Cartegni et al. 2003), relative enhancer and silencer
classification by unanimous enrichment (RESCUE-ESE)
(Fairbrother et al. 2004), exonic splicing regulator (ESR-
Search) (Fairbrother et al. 2002) and putative exonic
splicing enhancer (PESE) (Zhang et al. 2005) were used for
locating SNPs in exonic-splice regions.
F-SNP mines different tools to examine transcriptional
regulation and post-translational modification sites
Golden Path was mined to identify SNPs in transcriptional
regulatory regions (Kuhn et al. 2007). OGPET (Gerken
et al. 2004) was used to examine post-translational
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modification sites. OGPET predicted the O-glycosylation
sites (Lanver et al. 2010).
Predicting the phenotypic effect of nsSNPs
We employed the nsSNPAnalyzer (Bao et al. 2005) to
predict nsSNP’s phenotypic effect (disease associated vs.
neutral). nsSNPAnalyzer annotated the structural environ-
ment of each SNP site using the ENVIRONMENT pro-
gram (Bowie et al. 1991). The program combined three
parameters: (i) area of the side chain which was classified
as buried, partially buried and exposed according to its
solvent accessibility. The buried class was subdivided into
three classes (B1, B2 and B3) in order of increasing
environmental polarity. The partially buried class was
subdivided into P1 and P2 in order of increasing polarity.
The exposed side chain was labeled as E; (ii) fraction polar
score, giving a measure of environmental polarity related
to hydrogen bond formation; and (iii) secondary structure
(helix, sheet or coil). The server also integrated evolu-
tionary information and the normalized probability of the
substitution was calculated using SIFT program (Ng and
Henikoff 2003). nsSNPAnalyzer then used a machine
learning method, Random Forests (Bao et al. 2005), to
predict the phenotypic class of nsSNPs (Bao and Cui
2005).
Identifying highly conserved positions in protein
sequence
The ConSurf server was used for calculating the evolu-
tionary conservation of amino acid positions in proteins
using an empirical Bayesian inference (Ashkenazy et al.
2010). It automated the algorithmic tools to identify the
functionally important regions in query proteins by surface
mapping of the level of conservation of the amino acid sites
among their close sequence homologs (Glaser et al. 2003).
The conservation scores were divided into a discrete scale
of nine grades for visualization, from the most variable
positions (grade 1), through intermediately conserved
positions (grade 5), to the most conserved positions (grade
9) (Ashkenazy et al. 2010).
Comparative modeling of wild and mutant CASP9
proteins
Modeller 9.10, comparative modeling software was exe-
cuted to build protein models from the templates obtained
from sequence similarity with the target protein sequence
(Fisher and Sali 2003). The prediction process consisted of
target-template alignment, model building and model
evaluation (Eswar et al. 2007).
Analyzing the structural effect of protein upon mutation
SNPeffect server (Reumers et al. 2005) was employed to
analyze the structural effect of the nsSNP. The server uti-
lized the force-field FoldX (Guerois et al. 2002) to evaluate
the protein stability upon mutation. FoldX program esti-
mated the mutational free energy change on the stability of
a protein (Schymkowitz et al. 2005).
Hydrogen-bonding interactions
To understand intramolecular interactions upon mutations,
we have carried out an analysis of H-bonds across the wild
and mutant protein molecules, respectively. We employed
the Swiss-PDB viewer program to visualize protein com-
plexes and compute H-bonding (Guex 1996; Guex and
Peitsch 1996).
Results
Identification of nsSNPs and their selection using
F-SNP database
The F-SNP database resource (Lee and Shatkay 2008) lists
11 nsSNPs out of the 941 SNPs for CASP9 gene. They are
rs1052576, rs1052574, rs2308939, rs2308949, rs2308950,
rs1820204, rs2020897, rs2308938, rs2308941, rs9282624
and rs4646008. The corresponding allele change of these
nsSNPs is also obtained from F-SNP. SIFT and PolyPhen
tools are employed to obtain the corresponding changes in
the amino acid residues of these nsSNPs. F-SNP calculates
a specific functional significance (FS) score for each of
these nsSNPs which signifies their damaging effects (Lee
and Shatkay 2008, 2009). FS scores computed by F-SNP
database are found to be 0.774, 0.789, 0.977, 0.136, 0.318,
0.888, 0.916, 0.533, 0.749, 0.919 and 0.774 for the 11
nsSNPs rs1052576, rs1052574, rs2308939, rs2308949,
rs2308950, rs1820204, rs2020897, rs2308938, rs2308941,
rs9282624 and rs4646008, respectively, as depicted in
Table 1.
Functional prediction of nsSNPs using F-SNP database
F-SNP database predicts the deleterious effect of SNPs
with respect to protein coding, splicing regulation, tran-
scriptional regulation and post-translational effects (Lee
and Shatkay 2008). To obtain the damaging functional
effect of nsSNPs, F-SNP integrates multiple tools that are
based on different algorithms and computes the FS score
for each of them. The deleterious SNP has FS score value
between 0.5 and 1 (Lee and Shatkay 2009). Nine nsSNPs
(rs1052576, rs1052574, rs2308939, rs1820204, rs2020897,
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rs2308938, rs2308941, rs9282624 and rs4646008) are
found to have significant FS scores in the range of 0.5–1 as
depicted in Table 1.
The nsSNP, rs1052576, with FS score of 0.774 is found
to have a deleterious effect on the protein coding region as
predicted by SNP-effect tool. Splicing regulation system is
found to be altered by ESEfinder. Changes in transcrip-
tional regulatory region and in post-translational modifi-
cation site are examined by Golden Path and OGPET,
respectively. The nsSNP, rs1052574, with FS score of
0.789 is predicted to be damaging by SIFT, PolyPhen,
SNPeffect, LS-SNP and SNPs3D tools, which in turn are
queried by F-SNP database to predict the functional impact
on protein coding region. ESEfinder and ESRSearch pre-
dict changes in the splicing regulation system. Golden Path
examines a change in transcriptional regulatory region. For
nsSNP, rs2308939, with FS score of 0.977, protein coding
region is predicted to be deleterious by PolyPhen, SNPef-
fect and SNPs3D tools. Splicing regulation system, tran-
scriptional regulatory region and post-translational
modification site for rs2308939 are examined to have
changes by their respective tools (Table 2).
For nsSNP, rs1820204 with FS score 0.888, PolyPhen
predicts a deleterious effect in protein coding region.
Splicing regulation system, transcriptional regulatory region
and post-translational modification site for rs1820204 are
examined to have changes by their respective tools. The
nsSNP, rs2020897 with FS score 0.916, protein coding
region is predicted to be deleterious by SIFT and SNPs3D.
Changes in transcriptional regulatory region and in post-
translational modification site are examined by Golden Path
and OGPET, respectively. SNPs3D predicts a deleterious
effect on protein coding region for rs2308938 with FS score
of 0.533. A change in exonic-splice region is predicted by
Table 1 Lists of nsSNPs identified by F-SNP database with their corresponding alleles and amino acid changes
SNP ID F-SNP Amino acid change with position
SNP type Allele change FS score SIFT PolyPhen
rs1052576 Non-synonymous Ta/Gb 0.774 Qc(221)Rd Qc(221)Rd
rs1052574 Non-synonymous Ta/Ce 0.789 Lf(197)Pg Lf(197)Pg
rs2308939 Non-synonymous Ce/Ah 0.977 Rd(192)Si Rd(192)Si
rs2308949 Non-synonymous Gb/Ah 0.136 Gj(176)Rd Gj(176)Rd
rs2308950 Non-synonymous Gb/Ah 0.318 Rd(173)Hk Rd(173)Hk
rs1820204 Non-synonymous Ta/Ah 0.888 Fl(136)Lf Fl(136)Lf
rs2020897 Non-synonymous Gb/Ce 0.916 Em(114)Dn Em(114)Dn
rs2308938 Non-synonymous Ce/Ta 0.533 Lf(106)Fl Lf(106)Fl
rs2308941 Non-synonymous Ce/Ta 0.749 To(102)Ip To(102)Ip
rs9282624 Non-synonymous Ce/Gb 0.919 Ip(185)Mq Ip(185)Mq
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ESRSearch, PESE and RESCUE-ESE. Golden Path exam-
ines a change in the transcriptional regulatory region
(Table 2).
The nsSNP, rs2308941, with FS score 0.749 is predicted
to be deleterious by PolyPhen, SNPeffect and SNPs3D
tools. A change exists in exonic-splice region as predicted
by ESEfinder and ESRSearch. Changes in transcriptional
regulatory region and in post-translational modification site
are examined by Golden Path and OGPET, respectively.
For nsSNP, rs9282624 with FS score 0.919, PolyPhen
predicts a deleterious effect on protein coding region.
Changes in splicing regulation system and transcriptional
regulatory region are examined by their respective tools.
For nsSNP, rs4646008 with FS score 0.774, protein coding
region is predicted to be deleterious by PolyPhen and SNP-
effect. ESRSearch and RESCUE-ESE predict changes in
splicing regulation system. Changes in transcriptional
regulatory region and in post-translational modification site
are examined by Golden Path and OGPET, respectively
(Table 2).
Phenotypic effect of nsSNPs predicted
by nsSNPAnalyzer
The nine nsSNPs (rs1052576, rs1052574, rs2308939,
rs1820204, rs2020897, rs2308938, rs2308941, rs9282624
and rs4646008) having significant FS scores are annotated
by nsSNPAnalyzer to evaluate their phenotypic class
(disease associated vs. neutral) (Bao et al. 2005). The
ENVIRONMENT program (Bowie et al. 1991) evaluates
the structural environment of the SNP site based on three
structural parameters (area buried, fraction polar and sec-
ondary structure). Among these nine nsSNPs, rs1052574 is
annotated to be in the buried area (B1) with a score of
0.637 and fraction polar score of 0.188. A deleterious SIFT
score of 0.00 is also predicted for rs1052574 and hence,
this nsSNP is classified to be disease associated by
nsSNPAnalyzer. The nsSNP, rs2308939 is classified to be
neutral which is in the partially buried category of P2 with
area buried score of 0.351, fraction polar score of 0.771 and
SIFT score of 0.58. Another nsSNP, rs9282624 is classified
Table 2 Functional effect of nsSNPs by F-SNP database











Protein coding PolyPhen Benign Damaging Damaging Damaging Benign
SIFT Tolerated Damaging Tolerated Tolerated Damaging
SNP-effect Deleterious Deleterious Deleterious No entry Benign
LS-SNP Benign Deleterious Benign Benign Benign
SNPs3D Benign Deleterious Deleterious Benign Deleterious
Splicing ESEfinder Changed Changed Changed Changed Changed
Regulation ESRSearch Not changed Changed Changed Changed Changed
PESE Not changed Not changed Changed Changed Changed
RESCUE-ESE Not changed Not changed Changed Changed Changed
Transcriptional regulation Golden Path Exist Exist Exist Exist Exist









Protein coding PolyPhen Benign Damaging Damaging Damaging
SIFT Tolerated Tolerated Tolerated Tolerated
SNP-effect Benign Deleterious Benign Deleterious
LS-SNP Benign Benign Benign Benign
SNPs3D Deleterious Deleterious Benign No entry
Splicing regulation ESEfinder Not changed Changed Changed Not changed
ESRSearch Changed Changed Changed Changed
PESE Changed Not changed Changed Not changed
RESCUE-ESE Changed Not changed Changed Changed
Transcriptional regulation Golden Path Exist Exist Exist Exist
Post-translation OGPET Not exist Exist Not exist Exist
FS Functional significance
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to be neutral which is in the partially buried category of P2
with area buried score of 0.401, fraction polar score of
0.760 and SIFT score of 0.07. The other six nsSNPs
(rs1052576, rs1820204, rs2020897, rs2308938, rs2308941
and rs4646008) are not evaluated by the ENVIRONMENT
program. Hence, rs1052574 is predicted to be functionally
important. The phenotypic classes of nsSNPs are depicted
in Table 3.
Functionally important regions of protein identified
by the ConSurf server
To estimate the degree of conservation of the amino acid
residues among their close sequence homologs, we have
accessed the ConSurf server. Multiple sequence alignment
is obtained by CLUSTALW for the query protein
sequences with their respective homologous sequences,
and a position-specific conservation level score is assigned
for each amino acid residue in the alignment using the
empirical Bayesian algorithms (Ashkenazy et al. 2010).
The amino acid residue leucine at 197 position (L197) in
the native protein is found to be conserved with low neg-
ative normalized score of -1.048 and a high conservation
score of ‘9’. The mutated amino acid residue proline at 197
position (P197) for rs1052574 is also found to be conserved
with low negative normalized score of -0.920 and a high
conservation score of ‘8’.
Wild and mutant protein structures obtained
from Modeller 9.10
The 3D protein structures of both wild and mutant proteins
are obtained by comparative homology modeling (Eswar
et al. 2007). The program assigns the target sequence and
the database of sequences of known structure from PDB as
the input to obtain target-template alignments. A better
measure of the significance of the alignment is given by the
lower expected value (E-value) of the alignment which
helps to choose the suitable template candidates (Eswar
et al. 2007). The templates (1JXQA, 1NW9A and 2AR9A)
having E-value of 0.0 with better sequence coverage with
the query protein are chosen for significant sequence
alignments. A dendrogram is obtained, which calculates a
clustering tree from the input matrix of pairwise distances,
to understand the differences among the template candi-
dates (Eswar et al. 2007). The most appropriate template,
1JXQA, with 99 % sequence identity is selected for target-
template alignment and construction of the final model. We
have shown the native and mutant protein structures of
SNP rs1052574 in Fig. 1, where leucine (Leu) residue at
197 position in the native protein is replaced by proline
(Pro) residue in the mutant protein, showing helix to coil
transition.
Predicting protein stability changes upon mutation
The empirical protein design force-field FoldX (Guerois
et al. 2002) is used by SNPeffect (Reumers et al. 2005) to
calculate the difference in free energy of the mutation:
delta delta G (ddG). The homology model build for the
query protein sequence is evaluated by the FoldX program
and found that the mutation from leucine to proline at
position 197 results in a ddG of 7.74 kcal/mol.
Intramolecular H-bonding interactions
The significant nsSNP, rs1052574 of CASP9 producing the
amino acid variant L197P shows a helix to coil transition.
The effect of intramolecular interactions upon mutation is
analyzed by computing H-bonding in the wild and mutant
protein molecules. In the native CASP9 protein, leucine197
(L197) interacts with arginine (R193), showing a strong
H-bonding with a distance of 2.17 A˚ between N of L197
and O of R193, as depicted in Fig. 2. Amino acid substi-
tution from L197 to P197 shows a weak H-bonding in the
mutant protein with a distance of 3.16 A˚ between N of
P197 and O of R193, as represented in Fig. 2.
Discussion
We retrieved a total of 941 SNPs associated with CASP9
gene and identified 11 SNPs to be non-synonymous
(rs1052576, rs1052574, rs2308939, rs2308949, rs2308950,
rs1820204, rs2020897, rs2308938, rs2308941, rs9282624
and rs4646008). Among these, nine nsSNPs (rs1052576,
rs1052574, rs2308939, rs1820204, rs2020897, rs2308938,
rs2308941, rs9282624 and rs4646008) are found to have
significant FS scores in the range of 0.5–1. They are then
annotated to identify the disease-associated nsSNPs (Bao
et al. 2005). Among them, rs1052574 is annotated to be in
the buried area (B1) with a deleterious SIFT score of 0.00





SNP ID Area buried Fraction polar Environment Secondary structure SIFT score Phenotype
rs1052574 0.637 0.188 B1a Helix 0.00 Disease
rs2308939 0.351 0.771 P2b Helix 0.58 Neutral
rs9282624 0.401 0.760 P2b Helix 0.07 Neutral
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and is classified to be disease associated. If the area of the
side chain (A) [114 A˚2, the residue is placed in the envi-
ronment class B1 when fraction polar (f) \0.45. If
0.45 B f \ 0.58, then the environment class is B2 and the
environment class is B3 when f C 0.58. If 40 A˚2 \ A B
114 A˚2, the residue is placed in environment category P1
when f \ 0.67 and environment class P2 when f C 0.67. A
residue is placed in the exposed environment category E if
less than 40 A˚2 of the side chain is buried (Bowie et al.
1991). SIFT program (Ng and Henikoff 2003) uses an
empirical threshold: substitutions with normalized proba-
bilities \0.05 are predicted as deleterious while others are
predicted as tolerated. Buried area reflects the solvent
accessibility constraint and it is known that disease-asso-
ciated nsSNPs tend to occur at buried sites (Sunyaev et al.
2000). The SIFT score (Ng and Henikoff 2003) measures
the tolerance for a substitution in a multiple sequence
alignment and hence incorporates evolutionary informa-
tion. Thus, rs1052574, residing in the buried site (B1), is
predicted to be functionally important. The core residues
play a key role in protein folding and stability, and core
mutations are considered more deleterious than surface
mutations (Cordes and Sauer 1999). The other eight
nsSNPs (rs2308939, rs9282624, rs1052576, rs1820204,
rs2020897, rs2308938, rs2308941 and rs4646008) are not
classified to be disease associated and are not considered in
our study.
The significant change in protein coding region is found
for rs1052574 which replaces leucine197 in CASP9 protein
with proline due to the nucleotide change at 835th position
where CTG is replaced with CCG, i.e., T (thymine) to
C (cytosine). This indicates a transformation of acyclic
amino acid to a 5-membered amino acid residue. (The base
represented in bold caption is the nsSNP.) Putative ESEs
are also predicted for rs1052574 by the change in splicing
regulation region. ESEs are short oligonucleotide sequen-
ces other than splice sites that enhance splicing from an
exonic location. ESEs are recognized by proteins of the SR
(serine–arginine) family, which recruit components of the
core splicing machinery to nearby splice sites (Fairbrother
Fig. 1 The native and mutant
protein structures of SNP
rs1052574 where leucine (Leu)
residue at 197 position in the
native protein is replaced by
proline (Pro) residue in the
mutant protein, showing helix to
coil transition
Fig. 2 Intramolecular
interactions in the native (a) and
mutant (L197P) (b) of CASP9
protein models. a Hydrogen
bond with a distance of 2.17 A˚
between oxygen (O) of arginine
(R193) and nitrogen (N) of
leucine (L197) in the native
CASP9 protein. b Hydrogen
bond with a distance of 3.16 A˚
between oxygen (O) of arginine
(R193) and nitrogen (N) of
proline (P197) in the mutant
CASP9 protein
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et al. 2004). Numerous disease associated polymorphisms
exert their effects by disrupting the activity of ESEs (Smith
et al. 2006). The functionally important regions in these
proteins are identified by quantifying the conservation sta-
tus of amino acid residues among their close sequence
homologs (Ashkenazy et al. 2010; Glaser et al. 2003). Both
the wild and mutated amino acid residues at position 197 are
found to have high conservation score and low (negative)
normalized score. Low (negative) normalized scores indi-
cate the conserved positions, while the high scores indicate
the variable ones (Goldenberg et al. 2009). If an amino acid
in a particular position of a particular protein is conserved, it
indicates that this amino acid may be located in an impor-
tant or functional region of the protein and that its mutation
may cause a significant change of the protein’s structure and
function (Huang et al. 2010). Comparative study of protein
sequences among species infers preliminary information
about the protein function, and this has been reported in
many genetic diseases. Evolutionarily conserved amino
acid residues may serve as a hallmark to identify the
functionally critical amino acid of cancer-related genes that
may be mutated in tumors (Greenblatt et al. 2003).
Structural information is needed to fully understand the
effects and consequences of mutations (Khan and Vihinen
2007). The 3D protein structures of both wild and mutants of
CASP9 are obtained by executing comparative homology
modeling (Fisher and Sali 2003; Eswar et al. 2007). The
L197P substitution for SNP, rs1052574, shows a transition
from helix to coil in the modeled protein as shown in Fig. 1.
Proline is a very unusual amino acid, in that the side chain
cyclizes back on to the backbone amide position. Proline is
detrimental to the a-helical conformation for several rea-
sons. First, the amide proton is replaced by a -CH2 group, so
it is unable to participate in helix stabilization through
intramolecular H-bonding. Second, the bulkiness of its
pyrrolidine ring places steric constraints on the conforma-
tion of the preceding residue in the helix (Williamson 1994;
Li et al. 1996). Recent evidence suggests that L166P variant
in parkinson protein 7 confers reduced protein stability
which may be the underlying cause of early onset Parkin-
son’s disease (Moore et al. 2003). It is reported that the
L166P mutation is located in the a-helix 7 and is predicted to
lead to the unfolding of the C-terminal portion of parkinson
protein 7 due to the potent helix breaking properties of the
substituted proline (Moore et al. 2003). To analyze the
structural effect of the nsSNP, rs1052574 on CASP9 protein,
we evaluated the energetic impact of the protein upon
mutation from leucine to proline at position 197 (Guerois
et al. 2002). The mutational free energy change (ddG) is
evaluated by FoldX and is found to be 7.74 kcal/mol. The
FoldX error margin is around 0.5 kcal/mol. If the mutation
destabilizes the structure, ddG is increased, whereas stabi-
lizing mutations decrease the ddG (Schymkowitz et al.
2005). Our result implies that the mutation severely reduces
the protein stability. Correct folding and stability are
essential for protein function (Gidalevitz et al. 2009). It is
also interesting to note that this residue (L197) located in a
helix (Fig. 1) resides in the buried region of the native
protein (Table 3) and thus, mutation occurring in this resi-
due is critical for protein stability.
The proline substitution may be detrimental to the
a-helical conformation by disrupting intramolecular
H-bonding (Williamson 1994; Li et al. 1996). Therefore,
intramolecular interactions upon mutation are analyzed by
computing H-bonds in the native and mutant protein mol-
ecules. We have found strong H-bonding in the native
protein with a distance of 2.17 A˚ between L197 and R193,
whereas the substitution of L197 to P197 leads to weak
H-bonding in the mutant protein with a distance of 3.16 A˚
between P197 and R193 (Fig. 2). Thus, the substitution of
an acyclic amino acid (L197) to a 5-membered amino acid
residue (P197), occurring in the buried region of CASP9
protein with weak H-bond interactions, can be critical for
the stability in protein monomers. A considerable change in
the structure of the protein due to the nsSNP rs1052574 is
also observed which shows helix to coil transition in Fig. 1.
Hence, due to the change in the structure of the protein and
reduction in its stability, the function of the protein may be
altered, leading to decreased expression. Protein instability
caused due to mutation represents degradation of mutant
proteins which can be a prevalent disease-causing mecha-
nism. Degradation of mutant proteins has now been
strongly implicated in the etiology of a number of genetic
disorders (Waters 2001).
Apoptosis is responsible for the maintenance of
homeostasis in tissues as well as in embryonic develop-
ment. CASP9, belonging to a family of cysteine proteases,
is a key regulator of the apoptotic signaling system (Abel
et al. 2002). It is an interesting potential tumor suppressor
gene in NB, in part due to its localization to human chro-
mosome 1 band p36.1 (Soengas et al. 1999). Thus, the
nsSNP, rs1052574, with amino acid variant (L197P)
showing a deleterious phenotypic effect and reduced pro-
tein stability can decrease the function of the protein which
may lead to reduced expression of CASP9. Thereby, it can
alter the apoptotic signaling system which can be detri-
mental and result in the development of NB. Dysregulation
of apoptosis is likely to be instrumental in the development
of childhood tumor neuroblastoma, and it has been studied
that polymorphism in CASP9 gene leads to reduced
expression of the protein in NB tumors (Abel et al. 2005;
Abel et al. 2002). Mutations in genes encoding proteases,
as well as inhibitors and regulators of proteolytic pathways,
have been shown to cause numerous human diseases, both
inherited and acquired (oncogenic) (Kato 1999; Vu and
Sakamoto 2000).
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Hence, the results of the nsSNP, rs1052574, for CASP9
gene which is predicted to have a deleterious phenotypic
effect and reduced protein stability may be considered to be
significant, reducing the function of the apoptotic protease
cascade and thereby, leading to the development of neu-
roblastoma. Our results obtained from these in silico
studies, may provide an insight into the genetic mechanism
of the disease.
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